Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
162.28B
Market cap162.28B
Price-Earnings ratio
10.83
Price-Earnings ratio10.83
Dividend yield
3.26%
Dividend yield3.26%
Average volume
32.16M
Average volume32.16M
High today
$37.50
High today$37.50
Low today
$35.85
Low today$35.85
Open price
$36.36
Open price$36.36
Volume
19.08M
Volume19.08M
52 Week high
$91.90
52 Week high$91.90
52 Week low
$35.85
52 Week low$35.85

NVO News

The Motley Fool 1h
Scholar Rock Q4 2025 Earnings Transcript

Image source: The Motley Fool. Tuesday, March 3, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — David Hallal President and Head of Research &...

Scholar Rock Q4 2025 Earnings Transcript
Simply Wall St 6h
Assessing Novo Nordisk Valuation After Recent Share Price Weakness

Advertisement Event-driven snapshot of Novo Nordisk (NYSE:NVO) Novo Nordisk (NYSE:NVO) has drawn investor attention after its recent share performance, with t...

Assessing Novo Nordisk Valuation After Recent Share Price Weakness
TipRanks 7h
Novo Nordisk upgraded to Equal Weight from Underweight at Morgan Stanley

Morgan Stanley upgraded Novo Nordisk (NVO) to Equal Weight from Underweight with a price target of $40, down from $42. Post the selloff on the REDEFINE-4 data,...

Analyst ratings

59%

of 34 ratings
Buy
35.3%
Hold
58.8%
Sell
5.9%

More NVO News

TipRanks 23h
Novo Nordisk Employees Elect New Board Representatives Ahead of March AGM

An update from Novo Nordisk ( (NVO) ) is now available. On 2 March 2026, Novo Nordisk employees completed the election of new employee representatives to the c...

The Motley Fool 23h
Why I'm Not Worried About Novo Nordisk Stock

Novo Nordisk (NVO 0.37%) stock has been a trainwreck of late. In just the past 12 months, the Danish healthcare stock has lost around 60% of its value. Things h...

Why I'm Not Worried About Novo Nordisk Stock
TipRanks 23h
Eli Lilly Stock Falls as Rival Novo Nordisk Expands Weight-Loss Pill Manufacturing

Eli Lilly’s (LLY) stock is down 2% on reports that rival Novo Nordisk (NVO) is spending more than $500 million to expand the manufacturing of its Wegovy weight-...

TipRanks 1d
Novo Nordisk downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs analyst James Quigley downgraded Novo Nordisk (NVO) to Neutral from Buy with a price target of $41, down from $63. The firm cut estimates for Cagr...

TipRanks 4d
Prothena Announces $100 Million Share Repurchase Program

Prothena ( (PRTA) ) has shared an announcement. On February 27, 2026, Prothena announced that its board had authorized a share repurchase plan allowing the com...

TipRanks 4d
FDA approves Novo Nordisk’s Sogroya for three additional pediatric indications

Novo Nordisk (NVO) announced that the US Food and Drug Administration has approved three new indications for once-weekly Sogroya injection 5 mg, 10 mg, or 15 mg...

Simply Wall St 4d
Eli Lilly Advances Oral GLP 1 And Immunology Growth Story

Eli Lilly (NYSE:LLY) reported that its oral GLP-1 candidate orforglipron outperformed Novo Nordisk’s oral semaglutide in a head to head Phase 3 trial in adults...

Eli Lilly Advances Oral GLP 1 And Immunology Growth Story

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.